{
  "id": "5e2b1ed9fbd6abf43b000005",
  "type": "factoid",
  "question": "PDQ39 questionnaires is design for which disease?",
  "ideal_answer": "PDQ39 is Parkinson's Disease Questionnaire that is used for assessment of quality of life in patients with Parkinson's Disease.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29670566",
    "http://www.ncbi.nlm.nih.gov/pubmed/24035927",
    "http://www.ncbi.nlm.nih.gov/pubmed/30363378",
    "http://www.ncbi.nlm.nih.gov/pubmed/18543333",
    "http://www.ncbi.nlm.nih.gov/pubmed/23346238",
    "http://www.ncbi.nlm.nih.gov/pubmed/28290191",
    "http://www.ncbi.nlm.nih.gov/pubmed/28122431",
    "http://www.ncbi.nlm.nih.gov/pubmed/30108543",
    "http://www.ncbi.nlm.nih.gov/pubmed/29542093",
    "http://www.ncbi.nlm.nih.gov/pubmed/15778909",
    "http://www.ncbi.nlm.nih.gov/pubmed/28980176",
    "http://www.ncbi.nlm.nih.gov/pubmed/28770096",
    "http://www.ncbi.nlm.nih.gov/pubmed/29644334",
    "http://www.ncbi.nlm.nih.gov/pubmed/28805568",
    "http://www.ncbi.nlm.nih.gov/pubmed/17702633",
    "http://www.ncbi.nlm.nih.gov/pubmed/21163736",
    "http://www.ncbi.nlm.nih.gov/pubmed/16258207",
    "http://www.ncbi.nlm.nih.gov/pubmed/29215823",
    "http://www.ncbi.nlm.nih.gov/pubmed/23323136",
    "http://www.ncbi.nlm.nih.gov/pubmed/20347841",
    "http://www.ncbi.nlm.nih.gov/pubmed/16763974"
  ],
  "snippets": [
    {
      "text": "The outcomes assessed were motor symptoms with Unified PD Rating Scale III (UPDRSIII), functional mobility with Timed Up and Go Test (TUG), endurance with 6 min walking test (6MWT), freezing of gait with Freezing of Gait Questionnaire (FOG_Q), walking velocity with GAITRite and QL with PD Questionnaire (PDQ39). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28980176",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " They were assessed using SCOPA, Hoehn and Yahr Scale (HYS), Unified Parkinson's Disease Rating Scale (UPDRS), Parkinson's Disease Sleep Scale 2nd version (PDSS-2), Non-motor Symptoms Scale (NMSS), Montgomery Asberg Depression Scale (MADS), 39-item Parkinson's Disease Questionnaire (PDQ39), Neurogenic Orthostatic Hypotension Questionnaire (NOHQ), and Rapid Eye Movement Sleep Behaviour Disorder Questionnaire (RBDQ). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29215823",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The median PD questionnaire 39-score index (PDQ39-SI) was 23.22% and the most affected dimension was \"mobility.\" ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29670566",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In the 43% of cases in whom oral therapy was changed, total UPDRS improved significantly (effect size\u2009=\u20098) as did the PDQ39 in cases reaching target. NMS Quest and MOCA scores also improved significantly. This study shows that many people in a representative cohort of PD would benefit from objective assessment and treatment of their PD features against a target.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29644334",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here, we applied a novel diffusion-weighted imaging approach, diffusion MRI connectometry, to investigate the correlation of quality of life, evaluated by Parkinson's Disease Questionnaire (PDQ39) with the white matter structural connectivity in 27 non-demented PD patients (disease duration of 5.3\u00a0\u00b1\u00a02.9\u00a0years, H and Y stage\u00a0=\u00a01.5\u00a0\u00b1\u00a00.6, UPDRS-III\u00a0=\u00a013.7\u00a0\u00b1\u00a06.5, indicating unilateral and mild motor involvement). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29542093",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The present study aimed to assess the beneficial and side effects of STN DBS in Moroccan Parkinsonian patients. Material and Methods: Thirty five patients underwent bilateral STN DBS from 2008 to 2016 in the Rabat University Hospital. Patients were assessed preoperatively and followed up for 6 to 12 months using the Unified Parkinson's Disease Rating Scale in four conditions (stimulation OFF and ON and medication OFF and ON), the levodopa-equivalent daily dose (LEDD), dyskinesia and fluctuation scores and PDQ39 scale for quality of life (QOL).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30108543",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The total K-SCOPA-AUT score showed a positive correlation with other non-motor symptoms [the Korean version of non-motor symptom scale (K-NMSS)], activities of daily living (Unified Parkinson's Disease Rating Scale part II) and quality of life [the Korean version of Parkinson's Disease Quality of Life 39 (K-PDQ39)].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28122431",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS: Static posturography (Centre of Pressure -CoP- parameters), gait (the Ten-Meter Walk Test [TMWT]), freezing of gait (the Freezing of Gait Questionnaire [FOG-Q]), the motor portion of the Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and patient-perceived quality of life (the 39-item Parkinson's disease Questionnaire [PDQ39]), were assessed at pre-test, post-test, and re-test.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28290191",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The use of complementary and alternative medicine (CAM) therapy in nonmotor symptoms (NMS) for Parkinson disease (PD) is growing worldwide. Well-performed, systematic evidence-based research is largely lacking in this area and many studies include various forms of CAM with small patient numbers and a lack of standardization of the approaches studied. Taichi, Qigong, dance, yoga, mindfulness, acupuncture, and other CAM therapies are reviewed and there is some evidence for the following: Taichi in sleep and PDQ39; dance in cognition, apathy, and a mild trend to improved fatigue; yoga in PDQ39; and acupuncture in depression, PDQ39, and sleep.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28805568",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "One hundred thirty patients with PD completed a booklet of questionnaires, which included the PDQ39 as a disease-specific measure of QoL, a symptom checklist, a mobility checklist, as well as patient ratings of disease stage and disability.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18543333",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "At 70% sensitivity, the specificity for PDQ39 score and PD Symptoms Questionnaire score for the prediction of parkinsonism was 73.1% and 80.1%, respectively.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24035927",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Workers completed a health status questionnaire (PDQ39) and a Parkinson disease (PD) Symptoms Questionnaire.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24035927",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "As for specific questionnaires: the Parkinson`s Disease Questionnaire (PDQ-39) and the Parkinson's Disease Quality of Life Questionnaire (PDQL) have been described.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23346238",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "HRQOL was assessed with the EuroQol-5D and the specific questionnaire Parkinson's Disease Questionnaire-39 items.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21163736",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "One hundred thirty patients with PD completed a booklet of questionnaires , which included the PDQ39 as a disease-specific measure of QoL , a symptom checklist , a mobility checklist , as well as patient ratings of disease stage and disability . ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18543333",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here , we applied a novel diffusion-weighted imaging approach , diffusion MRI connectometry , to investigate the correlation of quality of life , evaluated by Parkinson 's Disease Questionnaire ( PDQ39 ) with the white matter structural connectivity in 27 non-demented PD patients ( disease duration of 5.3\u00a0\u00b1\u00a02.9\u00a0years , H and Y stage\u00a0=\u00a01.5\u00a0\u00b1\u00a00.6 , UPDRS-III\u00a0=\u00a013.7\u00a0\u00b1\u00a06.5 , indicating unilateral and mild motor involvement) . ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29542093",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The psychometric properties of the Dutch version of the Parkinson 's disease questionnaire 39 ( PDQ39-DV ) were tested in 177 patients with Parkinson 's disease ( PD) . ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702633",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study explored whether reflexology could improve or sustain the wellbeing of people with Parkinosn's Disease [PD] using the PDQ39 wellbeing tool designed specifically for use with people with PD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20347841",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS\nThe results of 27 patients for the Unified Parkinson's disease Rating Scale (UPDRS), Parkinson's Disease Questionnaire 39 (PDQ39) and Short Form 36 health survey questionnaire (SF36) were compared before surgery and after 12 months of bilateral STN DBS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15778909",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Evaluation of the Dutch version of the Parkinson's Disease Questionnaire 39.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702633",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The psychometric properties of the Dutch version of the Parkinson's disease questionnaire 39 (PDQ39-DV) were tested in 177 patients with Parkinson's disease (PD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17702633",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS: The results of 27 patients for the Unified Parkinson's disease Rating Scale (UPDRS), Parkinson's Disease Questionnaire 39 (PDQ39) and Short Form 36 health survey questionnaire (SF36) were compared before surgery and after 12 months of bilateral STN DBS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15778909",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Both disease-specific motor disabilities and quality of life (QOL) in the patients were evaluated using the Unified Parkinson's Disease Rating Scale (UPDRS) and the Parkinson's Disease 39 Quality of Life Questionnaire (PDQ39), respectively.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16258207",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS: Static posturography (Centre of Pressure -CoP- parameters), gait (the Ten-Meter Walk Test [TMWT]), freezing of gait (the Freezing of Gait Questionnaire [FOG-Q]), the motor portion of the Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and patient-perceived quality of life (the 39-item Parkinson's disease Questionnaire [PDQ39]), were assessed at pre-test, post-test, and re-test.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28290191",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS: The results of 27 patients for the Unified Parkinson's disease Rating Scale (UPDRS), Parkinson's Disease Questionnaire 39 (PDQ39) and Short Form 36 health survey questionnaire (SF36) were compared before surgery and after 12 months of bilateral STN DBS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15778909",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Methods: A pilot study was conducted in which laptops were distributed to 50 patients for 1 year to see whether such a service was feasible (in terms of patient participation and compliance) and whether this intervention affected the patient's condition, measured in UPDRS, Mini-Mental Status Examination (MMSE), 39-item Parkinson's Disease Questionnaire (PDQ39), and H &amp; Y Scale.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30363378",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "They were assessed using the K-NMSS, the Unified Parkinson's Disease Rating Scale (UPDRS), the Korean version of the Mini-Mental Status Examination (K-MMSE), the Korean version of the Montgomery-Asberg Depression Rating Scale (K-MADS), the Epworth Sleepiness Scale (ESS), and Parkinson's Disease Questionnaire 39 (PDQ39).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23323136",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Patients were also evaluated by using the Parkinson Disease Questionnaire -39 (PDQ39), the Unified Parkinson's Disease Rating Scale (UPDRS), the Mini Mental State Examination (MMSE) and the Frontal Assessment Battery (FAB).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28770096",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We investigated the impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of life (QOL) in patients with advanced Parkinson's disease, as self-assessed before and after surgery by completing the Parkinson's Disease Questionnaire (PDQ39).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16763974",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Parkinson's Disease"
}